Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -10.0% | +4.4% | 1 / 3 | -15.9% | +5.19 pp | +0.54 pp | +12.2% | 0.44 | 4.23 | 32,5 | −15,9% | 2,7 | −10,0% | 4.23 | 5.58 | −24,2% |
| Pts | 0 | 0 | 4 | 0 | 12 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 15.100 (close price on 2026-09-24)EPS (TTM): 3.570
Financial charts
1.Revenue & growth
VND bn32,5Q2/26
1.Revenue & growth
VND bn32,5Q2/26
2.Profit & growth
VND bn2,66Q2/26
3.Profit mix (Penman)
VND bn12,9Q2/26
4.Margins & cost structure
%17.3%Q2/26
5.Returns & cash cycle
% · days10.7%Q2/26
6.Earnings quality & cash
VND bn1,23Q2/26
7.Asset structure
VND bn131Q2/26
8.Funding & debt health
VND bn · times131Q2/26
9.Revenue backlog
VND bn0,09Q2/26
10.Valuation
times · %4,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %887Q2/26
Adjusted EPS growth, latest quarter
-10.0%
Average adjusted EPS growth, 3 quarters
4.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26